Date: 2015-02-09
Type of information: Resignation
Compound:
Company: Kymab (UK)
Therapeutic area:
Type agreement: resignation
Action mechanism:
Disease:
Details: * On February 9, 2015, Kymab announced that, due to his family commitments, Dr Christian Grøndahl will be stepping down as Chief Executive Officer of Kymab with immediate effect. Dr David Chiswell, Kymab’s
Chairman, takes over as interim CEO until a new, permanent CEO is appointed.
Financial terms:
Latest news:
